Skip to content

Clinical trials

Phase 3 Polyradiculoneuropathy, Chronic Inflammatory Demyelinating trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Phase: Phase 3 Country / region: Japan Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20122
20131
20141
20221
20242
20255

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting5
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi3
CSL Behring2
Takeda2
argenx2
Dianthus Therapeutics1
Nihon Pharmaceutical Co., Ltd1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating12
Autoimmune Diseases of the Nervous System1
Nervous System Diseases1
Polyradiculoneuropathy1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.